Nanocarriers: A novel strategy for the delivery of CRISPR/Cas systems

Nanocarriers: A novel strategy for the delivery of CRISPR/Cas systems

In recent decades, clustered regularly interspaced short palindromic repeat/CRISPR-associated protein (CRISPR/Cas) has become one of the most promising genome-editing tools for therapeutic purposes in biomedical and medical applications. Although the CRISPR/Cas system has truly revolutionized the er...

Full description

Bibliographic Details
Main Authors: Faranak Hejabi, Mohammad Sadegh Abbaszadeh, Shirinsadat Taji, Andrew O’Neill, Fatemeh Farjadian, Mohammad Doroudian
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Chemistry
Subjects:
nanocarriers
CRISPR/Cas9
gene therapy
nanomedicine
non-viral vector
Online Access:https://www.frontiersin.org/articles/10.3389/fchem.2022.957572/full

Internet

https://www.frontiersin.org/articles/10.3389/fchem.2022.957572/full

Similar Items